Biotechnology firm Biocon is foraying into the critical care segment aiming to provide treatment for hospital infections, including post surgical complications and trauma. There is a perceptible increase in hospital acquired infections with respect to critical care illnesses in
This often requires treatment with anti-infectives. Biocon's comprehensive care division has been set up to counter this growing challenge by providing affordable and specialised solutions to such patients. The company will introduce five new products in the initial phase of launch for the treatment of critical illnesses like septicemia and other acute hospital infections.
The new comprehensive care division will be the fifth division for the company, complementing the existing product portfolios in diabetology, oncology, nephrology and cardiology divisions.
crackcrack| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.80 |
| Dr. Reddys Lab | 1238.00 |
| Cipla | 1238.25 |
| Zydus Lifesciences | 942.95 |
| Lupin | 2333.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: